Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

25-03-2020 | Mental health | View from the clinic | Article

Glycemic happiness: Is there more to ‘good’ glucose control?

What is glycemic happiness and what are its benefits for diabetes practitioners and patients? Diabetologist Sanjay Kalra shares his view from the clinic.

GLP-1RAs: Evidence from the real world

Chaired by Melanie Davies, with Stewart Harris and Takashi Kadowaki, this new CME‑accredited webcast focuses on clinical decision making and treatment with GLP‑1RAs, based on real‑world data, and the emerging landscape of GLP‑1RAs in the context of approved guidelines.

31-03-2020 | SGLT2 inhibitors | Highlight | News

Cardioprotective benefits of dapagliflozin extend beyond people with diabetes

Treatment with dapagliflozin is associated with a significant reduction in the risk for heart failure worsening or cardiovascular death in people with heart failure and reduced ejection fraction regardless of whether or not they have diabetes, shows an exploratory analysis of DAPA-HF trial data.

ADVERTISEMENT

Guidance from the Improving Diabetes Steering Committee

Learn about SGLT2 inhibitor use in type 2 diabetes management

  • » The patient experience of diagnosis and self-management with SGLT2 inhibitors
  • » Translating SGLT2 inhibitor cardiovascular evidence into practice
  • » SGLT2 inhibitors: Key evidence and implications for clinical practice
  • » This content is intended only for UK healthcare providers and was made possible by educational funding provided by Napp Pharmaceuticals Ltd.

Latest from across the site

02-04-2020 | Cardiovascular outcomes | News

Add-on rivaroxaban has cardiovascular benefits irrespective of diabetes status

The addition of rivaroxaban to aspirin results in a similar relative reduction in the risk for cardiovascular events among patients with stable atherosclerosis and a history of atherosclerotic disease regardless of whether or not they have diabetes, suggests a subgroup analysis of the COMPASS trial.

01-04-2020 | Heart failure | News

Transplant study shows toxic effects of diabetes on the heart

Follow-up of patients after heart transplant reveals rapid cardiomyocyte lipid accumulation, a probable forerunner of diabetic cardiomyopathy, in those with pre-existing type 2 diabetes.

01-04-2020 | Liraglutide (obesity) | News

Liraglutide for weight loss successful in obese adolescents

Liraglutide 3.0 mg boosts weight loss in obese adolescents receiving lifestyle therapy, show the findings of a phase 3 trial.

31-03-2020 | Faster-acting insulin aspart | News

Onset 9: Faster aspart may have advantages over insulin aspart in advanced type 2 diabetes

Fast-acting insulin aspart results in equal, but not better, glycemic control to insulin aspart in adults whose long-standing type 2 diabetes is not adequately controlled with a basal–bolus regimen, a trial conducted in 17 countries suggests.

30-03-2020 | Older adults | News

Diabetes may compromise long-term outcomes in older people undergoing cardiac rehabilitation

Older people with and without diabetes experience similar short-term improvements in exercise capacity following cardiac rehabilitation, but those with diabetes fare worse after 1 year, EU-CaRE study results suggest.

27-03-2020 | Glycemic control | News

High blood glucose likely causal for unspecified dementia

A Mendelian randomization analysis supports a causal role of high blood glucose in unspecified dementia, but not in Alzheimer’s disease or vascular dementia.

ADVERTISEMENT

Flash glucose monitoring technology

Downloadable slide sets from key clinical trials in people with diabetes

Meet our UK Advisory Board

New Content Item Meet our international Editorial Board

Latest from us on Twitter

Trending this week

Image Credits